Postdoctoral Fellow — Protein Immunotherapy & Engineering

Dana-Farber Cancer Institute; Boston (MA); On-site; USD 72,000 - 76,000; Full time

Job summary

The Rashidian Lab at Dana-Farber Cancer Institute and Harvard Medical School is seeking a highly motivated postdoctoral fellow to develop next‑generation protein‑based immunotherapies for cancer and autoimmune diseases.

The successful candidate will lead an innovative project focused on design, engineering, and functional characterization of novel protein‑based immunotherapeutics, with opportunities for scientific independence and collaboration across immunology, protein engineering, and

Qualifications

• A PhD (or anticipated PhD) in protein engineering, immunology, molecular biology, bioengineering, or a related discipline.
• Strong research experience in protein engineering and/or immunology.
• Experience with recombinant proteins, antibody engineering, molecular biology, cellular immunology, or related techniques.
• A strong publication record appropriate to career stage, scientific creativity, and enthusiasm for developing new therapeutic approaches.
• Excellent communication skills, independence, and a collaborative mindset.

Responsibilities

• Lead an innovative project focused on design, engineering, and functional characterization of novel protein‑based immunotherapeutics.
• Collaborate with experts in immunology, protein engineering, cancer biology, and clinical oncology.
• Develop and translate therapeutic concepts toward clinical development.

Skills

Strong research experience

Excellent communication

Independence

Collaborative mindset

Education

PhD in related field

Tools

Antibody engineering

Molecular biology techniques

Cellular immunology

Job description

The Rashidian Lab at Dana-Farber Cancer Institute and Harvard Medical School is seeking a highly motivated postdoctoral fellow to develop next‑generation protein‑based immunotherapies for cancer and autoimmune diseases.

The successful candidate will lead an innovative project focused on design, engineering, and functional characterization of novel protein‑based immunotherapeutics, with opportunities for scientific independence and collaboration across immunology, protein engineering, and